Apixaban

Details

Files
Generic Name:
Apixaban
Project Status:
Complete
Therapeutic Area:
Venous thromboembolic events, treatment and prevention of recurrence
Manufacturer:
Bristol-Myers Squibb Canada and Pfizer Canada Inc. Alliance
Call for patient/clinician input open:
Brand Name:
Eliquis
Project Line:
Reimbursement Review
Project Number:
SR0397-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
Not achieved
Submission Type:
Initial
Indications:
Thromboembolic events (venous), treatment and prevention of recurrence
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: